Paul I Huang, MD
Pulmonary Disease · Los Gatos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 1 carrier
- Offices
- 3
Offices
3 locations · El Camino Health Medical Network LLC · 202 clinicians in this group
Looking this up.
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
12 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Huang’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A96717 · Current
Licensed to practise in California · since 2006 · expires 2028-08-31 · Rosalind Franklin University, the Chicago Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$79,326
Medicare paid this office $79,326 for 329 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Critical care, first 30-74 minutes | 93 | $29,639 | $185 |
| Return visit (30+ min) | 105 | $19,708 | $114 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 56 | $13,205 | $108 |
| Short return visit (20+ min) | 42 | $3,836 | $80 |
| New patient visit (45+ min) | 22 | $3,250 | $148 |
See all 8 services
| Critical care, first 30-74 minutes | 93 | $29,639 | $185 |
| Return visit (30+ min) | 105 | $19,708 | $114 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 56 | $13,205 | $108 |
| Short return visit (20+ min) | 42 | $3,836 | $80 |
| New patient visit (45+ min) | 22 | $3,250 | $148 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 31 | $3,078 | $67 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 21 | $2,636 | $115 |
| New patient visit (30+ min) | 24 | $2,333 | $97 |
Who their Medicare patients are
329 Original Medicare patients in 2024. Average age 78 · Under 65 3% · 85 and older 22% · Women 55% · Also on Medicaid 15% · Health risk score 1.73. At or below the middle of the specialty; the typical pulmonary disease clinician is at 2.13.
Conditions among them: High blood pressure 75% · COPD 41% · Coronary heart disease 39% · Diabetes 37% · Heart failure 36% · Chronic kidney disease 34% · Atrial fibrillation 34% · Depression 25% · Cancer 20% · Dementia 20% · Stroke 19%.
The office billed $362,997, Medicare allowed $104,170 and paid $79,326; for 632 services of 14 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 329 | 632 | 78 | 1.73 | $362,997 | $79,326 |
| 2023 | 338 | 887 | 78 | 2.04 | $547,433 | $121,101 |
| 2022 | 356 | 1,052 | 79 | 2.01 | $667,360 | $146,578 |
| 2021 | 275 | 533 | 76 | 2.31 | $422,173 | $68,829 |
| 2020 | 288 | 1,145 | 75 | 2.37 | $601,463 | $89,685 |
| 2019 | 321 | 911 | 76 | 2.98 | $637,849 | $101,562 |
| 2018 | 361 | 976 | 75 | 2.82 | $611,863 | $129,935 |
| 2017 | 308 | 1,001 | 75 | 2.63 | $489,209 | $122,390 |
| 2016 | 252 | 706 | 75 | 2.60 | $368,067 | $91,278 |
| 2015 | 282 | 823 | 76 | 2.48 | $439,112 | $120,849 |
| 2014 | 333 | 1,055 | 75 | 2.25 | $419,810 | $141,004 |
| 2013 | 307 | 1,005 | 75 | 2.31 | $323,225 | $132,901 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Critical care, first 30-74 minutes | 132 | $64,041 | $192 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 69 | $22,482 | $109 |
| Return visit (30+ min) | 80 | $15,324 | $114 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 30 | $5,020 | $73 |
| Short return visit (20+ min) | 56 | $4,976 | $75 |
| New patient visit (30+ min) | 28 | $2,947 | $105 |
| New patient visit (45+ min) | 13 | $1,996 | $154 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 16 | $1,908 | $119 |
2022: 8 services
| Critical care, first 30-74 minutes | 149 | $87,326 | $198 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 96 | $25,756 | $96 |
| Return visit (30+ min) | 71 | $11,734 | $114 |
| Short return visit (20+ min) | 61 | $5,776 | $78 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $3,545 | $66 |
| New patient visit (30+ min) | 30 | $3,106 | $104 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 24 | $3,063 | $128 |
| Telephone medical discussion with physician, 21-30 minutes | 11 | $754 | $69 |
2021: 8 services
| Critical care, first 30-74 minutes | 95 | $33,585 | $209 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 73 | $9,691 | $73 |
| Return visit (30+ min) | 49 | $8,750 | $123 |
| New patient visit (45+ min) | 24 | $3,809 | $159 |
| Short return visit (20+ min) | 34 | $3,227 | $85 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $2,673 | $107 |
| New patient visit (30+ min) | 22 | $2,354 | $107 |
| Telephone medical discussion with physician, 11-20 minutes | 14 | $271 | $19 |
2020: 11 services
| Critical care, first 30-74 minutes | 124 | $46,702 | $214 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 54 | $5,638 | $75 |
| Return visit (30+ min) | 50 | $4,636 | $79 |
| Telephone medical discussion with physician, 11-20 minutes | 45 | $3,670 | $71 |
| New patient visit (45+ min) | 14 | $2,116 | $151 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $2,062 | $90 |
| Telephone medical discussion with physician, 5-10 minutes | 49 | $1,954 | $37 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 20 | $1,333 | $43 |
| Telephone medical discussion with physician, 21-30 minutes | 11 | $1,269 | $106 |
| New patient visit (30+ min) | 12 | $1,038 | $86 |
| Short return visit (20+ min) | 16 | $598 | $37 |
2019: 6 services
| Critical care, first 30-74 minutes | 146 | $61,447 | $197 |
| Return visit (30+ min) | 96 | $15,491 | $92 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 31 | $6,217 | $93 |
| New patient visit (45+ min) | 28 | $4,287 | $153 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 37 | $3,691 | $66 |
| Test to measure expiratory airflow and volume | 12 | $209 | $17 |
2018: 9 services
| Critical care, first 30-74 minutes | 180 | $82,248 | $191 |
| Return visit (30+ min) | 129 | $21,041 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 45 | $8,887 | $92 |
| New patient visit (45+ min) | 45 | $6,712 | $149 |
| Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | 21 | $3,444 | $157 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 23 | $2,874 | $115 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 23 | $259 | $11 |
| Test to determine lung volumes using sensors | 23 | $243 | $11 |
| Test to examine how well the lungs exchange gases | 20 | $155 | $8 |
2017: 12 services
| Critical care, first 30-74 minutes | 159 | $74,982 | $184 |
| Return visit (30+ min) | 109 | $17,098 | $88 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 49 | $15,735 | $88 |
| New patient visit (45+ min) | 37 | $5,151 | $139 |
| Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | 18 | $2,465 | $123 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,607 | $115 |
| Administration of influenza virus vaccine | 11 | $355 | $32 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 26 | $284 | $11 |
| Test to determine lung volumes using sensors | 26 | $265 | $10 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 11 | $213 | $18 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 11 | $205 | $19 |
| Test to examine how well the lungs exchange gases | 20 | $149 | $7 |
2016: 7 services
| Critical care, first 30-74 minutes | 127 | $57,660 | $188 |
| Return visit (30+ min) | 102 | $15,340 | $87 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 35 | $9,338 | $89 |
| New patient visit (45+ min) | 18 | $2,373 | $132 |
| Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | 12 | $1,586 | $132 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,283 | $117 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 11 | $170 | $15 |
2015: 10 services
| Critical care, first 30-74 minutes | 151 | $82,375 | $206 |
| Return visit (30+ min) | 103 | $16,384 | $99 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 29 | $11,233 | $97 |
| New patient visit (45+ min) | 23 | $3,669 | $160 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 14 | $2,047 | $128 |
| Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | 11 | $1,671 | $152 |
| Test to measure expiratory airflow and volume | 14 | $464 | $33 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 16 | $350 | $19 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 11 | $136 | $12 |
| Test to examine how well the lungs exchange gases | 13 | $112 | $9 |
2014: 11 services
| Critical care, first 30-74 minutes | 172 | $100,701 | $193 |
| Return visit (30+ min) | 107 | $16,732 | $91 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 43 | $9,328 | $92 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 23 | $2,799 | $122 |
| New patient visit (45+ min) | 18 | $2,323 | $129 |
| Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | 16 | $1,857 | $116 |
| Test to measure expiratory airflow and volume | 19 | $763 | $35 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 34 | $631 | $17 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 22 | $258 | $12 |
| Test to determine lung volumes using sensors | 18 | $199 | $11 |
| Test to examine how well the lungs exchange gases | 22 | $180 | $8 |
2013: 12 services
| Critical care, first 30-74 minutes | 155 | $90,807 | $190 |
| Return visit (30+ min) | 72 | $12,086 | $94 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 44 | $9,887 | $90 |
| New patient visit (45+ min) | 34 | $4,968 | $146 |
| Irrigation and suction of lung airways to obtain cells using an endoscope | 14 | $1,848 | $123 |
| Short return visit (20+ min) | 23 | $1,625 | $60 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,301 | $118 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 13 | $1,142 | $88 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 28 | $491 | $16 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 25 | $276 | $11 |
| Test to examine how well the lungs exchange gases | 24 | $195 | $8 |
| Test to determine lung volumes using sensors | 11 | $128 | $12 |
Medicaid work
$2,845 in 2021
Medicaid paid $2,845 for 97 billed services this clinician did in 2021, up to 18 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 58 | $1,795 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 39 | $1,049 |
| 2021 | 97 | 2 | 18 | $2,845 |
| 2020 | 278 | 1 | 29 | $16,336 |
| 2019 | 146 | 1 | 26 | $7,449 |
| 2018 | 129 | 1 | 16 | $5,406 |
See the largest Medicaid services in earlier years
2020
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 278 | $16,336 |
2019
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 146 | $7,449 |
2018
| Critical care, evaluation and management of the critically ill or critically injured patient; first 30-74 minutes | 129 | $5,406 |
Drugs they prescribed that Part D paid
$174,900
Pharmacies billed $174,900 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 532) in 2024. At or below the middle of the specialty; the typical pulmonary disease clinician is at 0%.
261 generic and 271 brand-name prescriptions · $174,900 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Spiriva Handihaler | 45 | $49,231 | $1,094 |
| Trelegy Ellipta | 43 | $32,417 | $754 |
| Fluticasone-Salmeterol | 36 | $8,956 | $249 |
| Breo Ellipta | 22 | $8,700 | $395 |
| Tiotropium | 16 | $8,497 | $531 |
See all 14 drugs
| Spiriva Handihaler | 45 | $49,231 | $1,094 |
| Trelegy Ellipta | 43 | $32,417 | $754 |
| Fluticasone-Salmeterol | 36 | $8,956 | $249 |
| Breo Ellipta | 22 | $8,700 | $395 |
| Tiotropium | 16 | $8,497 | $531 |
| Wixela Inhub | 73 | $8,040 | $110 |
| Incruse Ellipta | 15 | $8,012 | $534 |
| Spiriva Respimat | 12 | $6,121 | $510 |
| Fluticasone Propionate Hfa | 12 | $4,427 | $369 |
| Qvar Redihaler | 11 | $3,171 | $288 |
| Albuterol Sulfate Hfa | 95 | $2,179 | $23 |
| Ventolin Hfa | 19 | $1,155 | $61 |
| Montelukast | 30 | $576 | $19 |
| Prednisone | 20 | $185 | $9 |
Year by year
| 2024 | 532 | 121 | 0% (0) | 51% | $174,900 |
| 2023 | 475 | 110 | 0% (0) | 69% | $175,091 |
| 2022 | 450 | 112 | 0% (0) | 77% | $162,016 |
| 2021 | 384 | 97 | 0% (0) | 67% | $131,325 |
| 2020 | 426 | 108 | 0% (0) | 68% | $128,629 |
| 2019 | 539 | 100 | 0% (0) | 71% | $202,391 |
| 2018 | 606 | 110 | 0% (0) | 79% | $295,827 |
| 2017 | 457 | 104 | 0% (0) | 79% | $252,762 |
| 2016 | 513 | 104 | 0% (0) | 78% | $252,251 |
| 2015 | 612 | 115 | 0% (0) | 74% | $178,150 |
| 2014 | 548 | 133 | 0% (0) | 82% | $112,339 |
| 2013 | 503 | 99 | None | 85% | $101,785 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 14 drugs
| Spiriva Handihaler | 64 | $64,578 | $1,009 |
| Trelegy Ellipta | 30 | $27,283 | $909 |
| Advair Diskus | 28 | $13,259 | $474 |
| Incruse Ellipta | 24 | $10,081 | $420 |
| Wixela Inhub | 40 | $9,798 | $245 |
| Symbicort | 12 | $8,594 | $716 |
| Flovent Hfa | 20 | $7,127 | $356 |
| Fluticasone-Salmeterol | 31 | $5,342 | $172 |
| Breo Ellipta | 11 | $4,730 | $430 |
| Albuterol Sulfate Hfa | 86 | $2,581 | $30 |
| Fluticasone Propionate Hfa | 13 | $2,129 | $164 |
| Ventolin Hfa | 19 | $1,368 | $72 |
| Montelukast | 22 | $513 | $23 |
| Prednisone | 23 | $297 | $13 |
2022: 13 drugs
| Spiriva Handihaler | 84 | $70,799 | $843 |
| Trelegy Ellipta | 26 | $19,736 | $759 |
| Symbicort | 19 | $14,788 | $778 |
| Advair Diskus | 31 | $13,214 | $426 |
| Incruse Ellipta | 29 | $11,033 | $380 |
| Flovent Hfa | 25 | $8,617 | $345 |
| Wixela Inhub | 28 | $5,880 | $210 |
| Fluticasone-Salmeterol | 26 | $4,276 | $164 |
| Albuterol Sulfate Hfa | 93 | $4,160 | $45 |
| Ventolin Hfa | 12 | $852 | $71 |
| Montelukast | 17 | $457 | $27 |
| Fluticasone Propionate | 11 | $145 | $13 |
| Prednisone | 13 | $126 | $10 |
2021: 11 drugs
| Spiriva | 73 | $64,768 | $887 |
| Trelegy Ellipta | 16 | $12,425 | $777 |
| Wixela Inhub | 35 | $10,364 | $296 |
| Symbicort | 16 | $8,680 | $542 |
| Flovent Hfa | 20 | $6,410 | $320 |
| Fluticasone-Salmeterol | 17 | $4,784 | $281 |
| Incruse Ellipta | 11 | $4,116 | $374 |
| Albuterol Sulfate Hfa | 75 | $3,271 | $44 |
| Ventolin Hfa | 22 | $1,841 | $84 |
| Montelukast | 24 | $470 | $20 |
| Prednisone | 17 | $146 | $9 |
2020: 9 drugs
| Spiriva | 86 | $58,511 | $680 |
| Wixela Inhub | 41 | $14,596 | $356 |
| Flovent Hfa | 37 | $11,033 | $298 |
| Symbicort | 23 | $10,172 | $442 |
| Albuterol Sulfate Hfa | 49 | $2,975 | $61 |
| Ventolin Hfa | 31 | $2,188 | $71 |
| Prednisone | 30 | $376 | $13 |
| Montelukast | 23 | $299 | $13 |
| Fluticasone Propionate | 11 | $277 | $25 |
2019: 12 drugs
| Spiriva | 99 | $64,445 | $651 |
| Advair Diskus | 58 | $33,045 | $570 |
| Incruse Ellipta | 31 | $14,089 | $454 |
| Symbicort | 34 | $13,342 | $392 |
| Wixela Inhub | 38 | $11,934 | $314 |
| Flovent Hfa | 34 | $10,329 | $304 |
| Ventolin Hfa | 41 | $3,435 | $84 |
| Proair Hfa | 27 | $2,027 | $75 |
| Montelukast | 44 | $996 | $23 |
| Albuterol Sulfate Hfa | 14 | $800 | $57 |
| Fluticasone Propionate | 15 | $195 | $13 |
| Prednisone | 28 | $179 | $6 |
2018: 15 drugs
| Esbriet | 13 | $119,711 | $9,209 |
| Spiriva | 98 | $53,589 | $547 |
| Advair Diskus | 78 | $44,749 | $574 |
| Symbicort | 55 | $20,836 | $379 |
| Incruse Ellipta | 37 | $15,744 | $426 |
| Flovent Hfa | 41 | $12,779 | $312 |
| Daliresp | 12 | $4,162 | $347 |
| Combivent Respimat | 11 | $4,068 | $370 |
| Proair Hfa | 43 | $3,744 | $87 |
| Ventolin Hfa | 50 | $3,630 | $73 |
| Montelukast | 37 | $1,082 | $29 |
| Prednisone | 29 | $359 | $12 |
| Fluticasone Propionate | 11 | $257 | $23 |
| Zolpidem | 11 | $67 | $6 |
| Furosemide | 14 | $25 | $2 |
2017: 11 drugs
| Spiriva | 120 | $55,913 | $466 |
| Advair Diskus | 62 | $30,448 | $491 |
| Symbicort | 30 | $10,775 | $359 |
| Flovent Hfa | 17 | $5,248 | $309 |
| Combivent Respimat | 13 | $4,554 | $350 |
| Daliresp | 13 | $4,246 | $327 |
| Proair Hfa | 33 | $2,458 | $74 |
| Ventolin Hfa | 29 | $2,079 | $72 |
| Montelukast | 31 | $485 | $16 |
| Prednisone | 20 | $233 | $12 |
| Zolpidem | 12 | $29 | $2 |
2016: 12 drugs
| Spiriva | 138 | $61,519 | $446 |
| Advair Diskus | 77 | $36,400 | $473 |
| Symbicort | 24 | $7,181 | $299 |
| Flovent Hfa | 22 | $5,666 | $258 |
| Combivent Respimat | 11 | $4,095 | $372 |
| Ventolin Hfa | 37 | $2,626 | $71 |
| Proair Hfa | 37 | $2,383 | $64 |
| Qvar | 11 | $1,789 | $163 |
| Modafinil | 11 | $804 | $73 |
| Montelukast | 38 | $711 | $19 |
| Prednisone | 19 | $108 | $6 |
| Zolpidem | 12 | $55 | $5 |
2015: 13 drugs
| Spiriva | 172 | $62,030 | $361 |
| Advair Diskus | 90 | $31,527 | $350 |
| Combivent Respimat | 19 | $5,670 | $298 |
| Dulera | 11 | $4,853 | $441 |
| Proair Hfa | 89 | $4,784 | $54 |
| Flovent Hfa | 14 | $3,768 | $269 |
| Symbicort | 11 | $3,489 | $317 |
| Montelukast | 64 | $967 | $15 |
| Ventolin Hfa | 12 | $559 | $47 |
| Modafinil | 11 | $487 | $44 |
| Zolpidem | 11 | $250 | $23 |
| Fluticasone Propionate | 16 | $232 | $14 |
| Prednisone | 26 | $196 | $8 |
2014: 10 drugs
| Spiriva | 165 | $60,320 | $366 |
| Advair Diskus | 66 | $23,078 | $350 |
| Proair Hfa | 119 | $6,025 | $51 |
| Symbicort | 17 | $5,333 | $314 |
| Combivent Respimat | 13 | $3,701 | $285 |
| Qvar | 19 | $3,064 | $161 |
| Montelukast | 32 | $765 | $24 |
| Ventolin Hfa | 11 | $473 | $43 |
| Azithromycin | 11 | $120 | $11 |
| Prednisone | 16 | $116 | $7 |
2013: 6 drugs
| Spiriva | 162 | $52,318 | $323 |
| Advair Diskus | 99 | $29,537 | $298 |
| Proair Hfa | 94 | $4,555 | $48 |
| Flovent Hfa | 11 | $2,379 | $216 |
| Montelukast | 19 | $614 | $32 |
| Zolpidem | 23 | $198 | $9 |
Money from drug and device companies
$37 in 2025
| 2025 | 2 | 2 | None | $37 |
| 2023 | 1 | 1 | None | $24 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Octapharma USA | Balfaxar | $19 | 1 payment
|
| Insmed | Brinsupri | $17 | 1 payment
|
See all 2 published payments
| Insmed | Education · 2025-09-10 | Brinsupri | $17 |
| Octapharma USA | Meals · 2025-06-19 | Balfaxar | $19 |
See earlier years (2023)
2023: $24
| Exact Sciences | Cologuard Collection Kit | $24 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 94.9 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1689753337
- Licence
- CA A96717California A96717: Current · expires 2028-08-31
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RP1001X (207RP1001X); Federal specialty code 207RC0200X (207RC0200X)
- Mailing address
- 2425 Samaritan Dr, San Jose, CA, 95124
- NPI first listed
- 2006-11-03
- NPI last updated
- 2023-11-14
- NPI record certified
- 2023-11-14
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 2585 Samaritan Dr, San Jose, CA, 95124